Sansawi, Almoidz Y.

HRN: 22-95-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2023
CEFOTAXIME 500MG (VIAL)
04/25/2023
05/01/2023
IVTT
285mg
Q6h
PCAP C, Bfc, T/C Sepsis
Waiting Final Action 
04/25/2023
AMPICILLIN 1GM (VIAL)
04/25/2023
05/01/2023
IVTT
285mg
Q12h
PCAP C, BFC, T/C SEPSIS
Waiting Final Action 
04/26/2023
MUPIROCIN 2%, 15G (TUBE)
04/26/2023
05/03/2023
TOPICAL
Pea Size
BID
Staphylococcal Infection
Waiting Final Action 
04/27/2023
MUPIROCIN 2%, 15G (TUBE)
04/27/2023
05/04/2023
TOPICAL
1gram
TID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: